Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study

NCT07033624 is registered in ClinicalTrials.gov with Harbin Medical University as lead sponsor.

NCT NCT07033624
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07033624 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study
Lead sponsor
Harbin Medical University
Phase
Observational
Overall status
Not yet recruiting
Start date
July 1, 2025
Completion date
July 1, 2047
Enrollment
10,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases